GL - Globe Life Inc. Stock Analysis | Stock Taper
Logo
Globe Life Inc.

GL

Globe Life Inc. NYSE
$159.18 3.16% (+4.87)

Market Cap $12.36 B
52w High $159.36
52w Low $116.73
Dividend Yield 0.80%
Frequency Quarterly
P/E 11.02
Volume 299.36K
Outstanding Shares 77.64M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q1-2026 $1.56B $401.9M $270.53M 17.35% $3.45 $368.13M
Q4-2025 $1.52B $106.35M $266M 17.45% $3.35 $379.27M
Q3-2025 $1.51B $147.7M $387.84M 25.63% $4.81 $513.24M
Q2-2025 $1.48B $143.18M $252.75M 17.06% $3.09 $348.18M
Q1-2025 $1.48B $143.74M $254.56M 17.2% $3.05 $351.07M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q1-2026 $439M $30.97B $24.88B $6.08B
Q4-2025 $18.05B $30.81B $24.84B $5.97B
Q3-2025 $18.16B $30.53B $24.84B $5.69B
Q2-2025 $17.72B $29.81B $24.39B $5.42B
Q1-2025 $17.87B $29.71B $24.28B $5.43B

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q1-2026 $270.53M $420.94M $-281.26M $-29.63M $110.5M $396.03M
Q4-2025 $266.08M $350.6M $-265.84M $-241.01M $-158.01M $330.1M
Q3-2025 $387.84M $305.98M $-73.79M $-171.79M $63.59M $208.69M
Q2-2025 $252.75M $307.93M $-64.03M $-230.78M $6.85M $294.99M
Q1-2025 $254.56M $431.89M $-239.95M $-124.46M $66.94M $420.14M

Revenue by Products

Product Q1-2025Q2-2025Q4-2025Q1-2026
Health Segment
Health Segment
$370.00M $380.00M $780.00M $420.00M
Life Segment
Life Segment
$830.00M $840.00M $1.69Bn $850.00M

Q1 2026 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at Globe Life Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

Globe Life combines a focused market niche with solid, recurring profitability and strong cash generation. Its distribution network—mixing direct‑to‑consumer channels with an extensive captive agency force—gives it broad reach into underserved customer segments. Financially, it benefits from steady revenue growth, robust margins, and high free cash flow that comfortably supports dividends and buybacks. The balance sheet shows a stable asset base and growing retained earnings, while operational initiatives in automation and digital tools reinforce efficiency over time.

! Risks

Key concerns include rising leverage as debt increases to help fund shareholder returns, a relatively thin short‑term liquidity buffer by simple ratio measures, and some opacity in the reported figures, such as the anomalous disappearance of certain income‑statement lines in the latest year. The customer base is more vulnerable to economic stress, which can affect policy sales and persistency. The company also faces the usual insurance sector challenges—regulatory change, interest‑rate and credit risk, and potential competition from both large incumbents and digital newcomers—without the cushion of a large formal R&D program to drive step‑change innovation.

Outlook

The overall trajectory appears one of steady, incremental progress rather than dramatic transformation. If Globe Life continues to execute its niche strategy, maintain underwriting discipline, and carefully manage its balance sheet, it seems positioned to sustain solid earnings and cash flow. Future outcomes will hinge on how well it balances generous capital returns with rising leverage, how effectively it deploys technology to keep its distribution advantage, and how resilient its target customers prove to be through economic cycles. Clarifying the recent reporting anomalies and maintaining conservative risk management will be important for sustaining confidence in this otherwise stable profile.